Sinus Tissue Resection Market To Reach $311.4 Million By 2030

Sinus Tissue Resection Market Growth & Trends

The global sinus tissue resection market size is expected to reach USD 311.4 million by 2030, registering to grow at a CAGR of 5.08% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing incidence of chronic diseases such as asthma, rhinitis, and allergies and the rising competition among key industry participants are the major factors contributing to the market growth. Companies operating in the industry, such as Integra LifeSciences and Medtronic plc, are acquiring other companies to strengthen their presence in the industry and boost the product portfolio for sinus and ENT surgeries.

The growing incidences of chronic disorders such as rhinitis and Asthma are expected to boost the sinus tissue resection market growth over the forecast period. According to an article published by the WHO in May 2023, approximately 455,000 individuals worldwide died due to Asthma in 2019. In addition, Asthma affected 262 million individuals. Moreover, sinusitis is associated with severe asthma patients. So, having Asthma increases the chances of acquiring a sinus infection. Thus, the rising incidences of Asthma are anticipated to boost the sinus tissue resection market growth in the coming years.

Furthermore, the rising technological advancements and product launches are expected to propel market growth in the coming years. Manufacturers and researchers are developing advanced products to help during sinus surgeries. For instance, according to the study published by Springer Nature Limited in February 2022, a steerable, functional, single-handed endoscope, PliENT, has been developed for maxillary sinus surgery. The performance of the endoscope was inspected in this study. Using this endoscope, an increased field of view can be obtained compared to currently utilized endoscopes. Thus, such novel endoscope developments for sinus and ear nose and throat (ENT) procedures are expected to boost market growth.

 Request a free sample copy or view report summary: Sinus Tissue Resection Market Report

Sinus Tissue Resection Market Report Highlights

• The endoscope sub-segment dominated the product segment, with a revenue share of 35.9% in 2024, owing to the increasing adoption of minimally invasive procedures.

• The nasal scissors product segment is expected to grow at the fastest CAGR from 2025 to 2030, due to the availability of nasal scissors from several industry players, such as Integra LifeSciences Corporation, Surtex Instruments, and Millennium Surgical.

• Based on end-use, the hospital segment dominated the market with a revenue share of 41.80% in 2024, due to the presence of a large number of hospitals conducting various ear nose and throat procedures.

• The clinics end-use segment is expected to register the fastest CAGR in the coming years, owing to advantages such as lower costs associated with clinic facilities.

Sinus Tissue Resection Market Segmentation

Grand View Research has segmented the global sinus tissue resection market based on product, end-use, and region:

Sinus Tissue Resection Product Outlook (Revenue in USD Million) 2018-2030

• Endoscopes

• Ethmoid Forceps

• Nasal Scissors

• Curetts

• Others

Sinus Tissue Resection End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers

• Clinics

• Others

Sinus Tissue Resection Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Norway

  • Sweden

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Sinus Tissue Resection Market

• Medtronic

• Stryker (Entellus Medical, Inc.)

• INTEGRA LIFESCIENCES

• B. Braun Melsungen AG

• Stille[AP20]

• KARL STORZ

• CARDIMED INTERNATIONAL

• Novo[AP21] Surgical Inc.

• Surtex Instruments

• Xelpov Surgical